With the recent development of new hybrid compounds having histamine H3 receptor antagonist with combined histamine N τ-methyltransferase (HMT) inhibitory potency an innovative approach was described in the research of novel lead compounds modulating histaminergic neurotransmission. Several compounds containing an ether moiety derived from the recently published 4-(3-piperidinopropoxy) phenylaminoquinoline derivatives ( ...